FDA Inspection
e+ Oncologics Louisiana, L.L.C.e+ Oncologics Louisiana, L.L.C. – FDA Inspection, Mar 28, 2022
Record Details
This FDA Inspection record concerns e+ Oncologics Louisiana, L.L.C., with an inspection on March 28, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 28, 2022
- Product Type
- Biologics
View Company Profile
ID · e2c5bdae-ef32-4608-a312-bdcb1f222b44
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1171283
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of e+ Oncologics Louisiana, L.L.C.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 9, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 18, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 21, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 13, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 26, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for e+ Oncologics Louisiana, L.L.C.
- FDA Inspection 1244909 - 2024-07-09
- FDA Inspection 1044991 - 2018-01-18
- FDA Inspection 945916 - 2015-10-21
- FDA Inspection 878411 - 2014-05-13
- FDA Inspection 793769 - 2012-07-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.